Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention

By  

Current Medicinal Chemistry, Vol. 21, Iss. 22, 2014-07 ,pp. : 2510-2521

Bentham Science Publishers

Access to resources Recommend Favorite

Variation in hospital treatment patterns for metastatic colorectal cancer

By Krell Robert W.   Regenbogen Scott E.   Wong Sandra L.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1755-1761

Blackwell Publishing

Access to resources Recommend Favorite

Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors

By Ackerman Allison   Klein Oliver   McDermott David F.   Wang Wei   Ibrahim Nageatte   Lawrence Donald P.   Gunturi Anasuya   Flaherty Keith T.   Hodi F. Stephen   Kefford Richard   Menzies Alexander M.   Atkins Michael B.   Long Georgina V.   Sullivan Ryan J.  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1695-1701

Blackwell Publishing

Access to resources Recommend Favorite

Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?

By Price Timothy J.   Beeke Carol   Ullah Shahid   Padbury Robert   Maddern Guy   Roder David   Townsend Amanda R.   Moore James   Roy Amitesh   Tomita Yoko   Karapetis Christos  

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 830-835

Blackwell Publishing

Access to resources Recommend Favorite

Pharmacokinetic Modelling of 5-FU Production from Capecitabine—A Population Study in 40 Adult Patients with Metastatic Cancer

By Urien Saik   Rezaí Keyvan   Lokiec François  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 5-6, 2005-12 ,pp. : 817-833

Springer Publishing Company

Access to resources Recommend Favorite